Carlson Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-835,000
Closed -$32.8M 173
2023
Q2
$32.8M Buy
+835,000
New +$29.5M 2.81% 7

Carlson Capital's ISEE Position: Q3 2023 in Review

Carlson Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 835,000 shares — an estimated $32.8M sold.

Carlson Capital first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $32.8M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Carlson Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Carlson Capital sold 835,000 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $32.8M.
  • Carlson Capital first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Carlson Capital's IVERIC bio, Inc. Common Stock position peaked at $32.8M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Carlson Capital's 13F filing for Q3 2023, filed 14 Nov 2023.